博謙生技股份有限公司

他達拉非
Tadalafil

• 主成分: Tadalafil Assay by HPLC (on dried basis)：Not less than 97.5% and not more than 102.0% w/w.
• 適應症: 治療勃起功能障礙。

硫酸氫克洛平格
Clopidogrel Bisulfate

• 主成分: Clopidogrel Bisulfate contains not less than 97.0 percent and not more than 101.5 percent of C16H16ClNO2S‧H2SO4, calculated on the dried basis.
• 適應症: 抗凝血劑

磷酸西他格列吡汀
Sitagliptin Phosphate Monohydrate

• 主成分: Sitagliptin Phosphate Monohydrate Assay by HPLC (on anhydrous and solvent free basis): Not less than 98.0% w/w and not more than 102.0% w/w.
• 適應症: 糖尿病治療用藥

伏利沙恩凍晶注射液200毫克
Vorisam Lyophilized Powder for Injection 200mg

• 主成分: VORICONAZOLE
• 適應症: 一、治療侵犯性麴菌病（INVASIVE ASPERGILLOSIS）﹔二、治療嚴重之侵犯性念珠菌感染（SERIOUS INVASIVE CANDIDA INFECTIONS）﹔三、治療足分枝菌（SCEDOSPORIUM SPP.）和鐮刀菌（FUSARIUM SPP.）之嚴重黴菌感染﹔四、預防高危險患者發生侵入性黴菌感染，包括接受造血幹細胞移植（HSCT）的患者。

泰百黴素
Tobramycin

• 主成分: Tobramycin contains not less than 94.0%~100.0% of C18H37N5O9 (dried substance).
• 適應症: 抗生素

"博謙"阿扎賽德苷
Azacitidine "PharmaCore"

• 主成分: Azacitidine Assay: 98.0%~102.0% on the anhydrous and solvent-free basis.
• 適應症: 治療骨髓發育不良症候群。

帕瑞昔布鈉
Parecoxib Sodium

• 主成分: Parecoxib Sodium contains not less than 98.0% and not more than 102.0% of C19H17N2O4SNa, calculated on the dried basis.
• 適應症: 使用於外科手術後疼痛之緩解

"博謙"硼替佐米
Bortezomib "Pharmacore"

• 主成分: Bortezomib Assay:97.0% to 103.0% on the anhydrous basis.
• 適應症: 治療多發性骨髓瘤。

鹽酸氯林絲菌素
Clindamycin Hydrochloride

• 主成分: Clindamycin Hydrochloride Assay (on anhydrous basis): Not less than 800μg/mg
• 適應症: 抗生素